What is the success rate of Xanax? (3 stories)
By
Ivan Kahwa
Author bio
Mr Ivan Kahwa is a chemist and phytopharmaceutical scientist with expertise in chemistry, pharmacology, phytochemistry, and Nanobiotechnology. He writes and reviews content on these topics.
Mr Ivan Kahwa’s Highlights:
Guest Researcher at the University of Leipzig, Senior Research Fellow/Scientist, and Lecturer at the Department of Pharmacy, Faculty of Medicine, Mbarara University of Science and Technology.
Professional Experience:
Mr Ivan joined PHARMBIOTRAC as a research fellow/scientist during his master of science tenure. He contributed to the development of most of the phytopharmaceutical products in the project. Furthermore, he participated in carrying out the pharmacological activities of the developed products in laboratory animals such as mice and rats in order to develop proper doses hence leading to pre-clinical studies.
With the above relevant research experience, Ivan started to work with the University of Leipzig on collaborative projects with Mbarara University to develop the chemistry of Ugandan Medicinal plants and their pharmacological activities. This was coupled with several consultative positions by different German NGOs. Mr. Kahwa is also a supporting in the teaching and learning at the Departments of Pharmacy and Pharmaceutical Sciences, Faculty of Medicine, Mbarara University of Science and Technology.
With the increase in antimicrobial resistance globally, Ivan retooled his thinking towards developing new naturally derived antibiotic regimens from Ugandan propolis with the assistance of nanotechnology to improve their delivery to microbial cells. Kahwa has also published over 28 articles in peer-reviewed journals and he is currently reviewing for many journals.
Education:
2023-2027: PhD in Pharmaceutical Sciences (ongoing) with a focus on Pharmaceutical Microbiology and Nanobiology at Mbarara University of Science and Technology.
2022: 2Msc. in Pharmacognosy and Natural Medicine Science at Mbarara University of Science and Technology.
2018: Bachelor of Science (Chemistry) at Mbarara University of Science and Technology.
Publications:
▪ Iqbal, S., Jabeen, F., Kahwa, I., & Omara, T. 2023. Suberosin Alleviates Thiazolidinedione-Induced Cardiomyopathy in Diabetic Rats by Inhibiting Ferroptosis via Modulation of ACSL4-LPCAT3 and PI3K-AKT Signaling Pathways. Cardiovascular Toxicology. https://doi.org/10.1007/s12012-023-09804-7
▪ Gupta, A. K., Yadav, R., Sharma, S., Sawale, J., & Kahwa, I. 2023. Anti-ageing Activity and Antioxidant Activity of Methanol Extracts of Leaves and Flowers of Salvia officinalis and Rosmarinus officinalis. Journal of Young Pharmacists, 15(3), 448–455. https://doi.org/10.5530/jyp.2023.15.60
▪ Tolo, C.U., Kahwa, I., Nuwagira, U., Weisheit, A. and Ikiriza, H., 2023. Medicinal plants used in treatment of various diseases in the Rwenzori Region, Western Uganda. Ethnobotany Research and Applications, 25, pp.1-16.
https://ethnobotanyjournal.org/index.php/era/article/view/4683
▪ Kahwa, I., Ajayi, C.O., Yadav, R., Chauhan, N.S., Shah, K., Abdelgadir, A.A., Shegena, E.A., Daniel, S., Omara, T., Asiimwe, J.B. and Ikiriza, H., 2023. Pharmacognostic and phytochemical studies as an invaluable approach for correct identification of medicinal plants: The case of Artemisia vulgaris L. substituted for Artemisia annua L. in Western Uganda. TMR Integr Med, 7, p.e23004.
https://doi.org/10.53388/TMRIM202307004
▪ Nalimu, F., Oloro, J., Kahwa, I. and Ogwang, P.E., 2021. Review on the phytochemistry and toxicological profiles of Aloe vera and Aloe ferox. Future Journal of Pharmaceutical Sciences, 7, pp.1-21.
https://doi.org/10.1186/s43094-021-00296-2
▪ Elamin, O.H.S., Ali, M.A., Elgezuli, I.A.A., Bashir, M.A. and Kahwa, I., 2021. Diagnosis of pre-and post-treatment of echinococcus granulosus with counter current immune electrophoresis and bacterial co-agglutination. Journal of Microbiology and Infectious Diseases, 11(02), pp.88-94.
https://doi.org/10.5799/jmid.951600
Published book Chapter
▪ Kahwa, I., Ayesiga, I., Nakalema, S., Alinaiswe, R., Mbabazi, R. and Iqbal, S., 2023. Natural products in the management of onchocerciasis. In Natural Products in Vector-Borne Disease Management (pp. 63-80). Academic Press. Book Chapter.
https://doi.org/10.1016/B978-0-323-91942-5.00012-4
Submitted manuscripts Under Review:
▪ Comparison of the Wound Healing Activity of the Leaf and Leaf Ash Extracts of Vernonia amygdalina in Rats. Journal name: Clinical Phytoscience
▪ Ethnobotanical Survey of Medicinal plants used in the management of cancer in Uganda. Journal name: Journal of Herbal Medicine
▪ Ethnobotanical survey and phytochemical screening of medicinal plants used in treatment of epilepsy by PROMETRA-Uganda Traditional Health Practitioners in Mpigi District, Uganda. Journal name: Journal of Ethnopharmacology
Submitted book chapters under review
1.Book title: Algae as a Natural Solution for Water-Food-Energy Nexus, Section 4: Microalgae and cyanobacteria for food applications, Chapter 4.6: Safety, toxicological and allergenic aspects of using algae for food. Authors: Christine Kyarimpa, Tom Omute, Caroline K. Nakiguli, Alice V. Khanakwa4, Christopher Angiro, Ivan Kahwa, Fortunate Ahumuza, Timothy Omara*. Publisher: Springer Nature Singapore Pte Ltd. 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore.
2.Book title: Nutraceuticals Inspiring the Contemporary Therapy for Lifestyle Diseases. Chapter: Nutraceutical applications of Seaweeds and their Phytocompounds in Nutrition and Treatment of Diseases. Authors: Ivan Kahwa, Timothy Omara , Innocent Ayesiga , Gael Noel Neh Neba Ambe , Zehbanaz Javidbhai Panwala , Rachel Mbabazi , Shabnoor Iqbal , Christine Kyarimpa , Christine Betty Nagawa , Kamal Shah ,Nagendra Singh Chauhan* Publisher: CRC Press
You can view my works on the following professional sites:
Research Gate: https://www.researchgate.net/profile/Ivan-Kahwa
Google Scholar: https://scholar.google.com/citations?user=tOwrvqoAAAAJ&hl=en
ORCID: https://orcid.org/0000-0002-6440-3437
Linkedin: https://de.linkedin.com/in/ivan-kahwa-865450159
This article will discuss some Xanax success stories. We will also discuss the overall success rate of this antidepressant and the conditions it is approved to manage and treat.
What is the success rate of Xanax?
Xanac has a success rate of 75-85%. It belongs to a class of drugs known as benzodiazepines and is used in the treatment and management of several health conditions including anxiety.
However, the success rate can vary from person to person, and it is important to note that what works for one may not work as effectively for another. Genetic differences play a significant role in this variation, affecting how our bodies process and react to medications.
Some individuals report significant mood improvement and a reduction in anxiety symptoms, while others may not experience the same level of positive effects. Always discuss these points with a healthcare provider to ensure a safe and effective therapeutic outcome.
What have people experienced so far?
Many people have experienced amazing benefits from using Xanax. However, Xanax also caused addiction in some people who misused it. Many people shared their experiences of how Xanax have turned their lives.
A 43-year-old Richard stated:
I had been suffering from anxiety since I was 18. I used to obsess over every task and could not seem to control my thoughts. This situation worsens after some time. Initially, I felt ashamed of visiting a mental healthcare professional but when I had no other option, I visited a mental healthcare provider.
He continued:
The doctor advised me to take Xanax 0.5mg initially. It literally changed my life and calmed my nerves. I experienced some side effects initially but they were easier to handle compared to what I was originally going through. Ten years have passed and I still rely on Xanax. It is now my friend.
A 76-year-old Linda shared her story:
I never liked taking medications. Seven years back, I struggled with insomnia and was in dire need of some medication. I was unable to eat and ended up with severe anxiety. It is not possible for a person to stay awake for such an extended period.
He further stated:
After taking Xanax for the first time, I felt my eyes getting closed within 40 minutes of my first dose. It has worked like a miracle for me and my anxiety. Xanax had been by my side all this time. It actually saved my life from ruining.
33-year-old Emma shared her story:
Xanax has worked amazingly for my anxiety. I refused to take Xanax as I was too young only 21 years old. I was too young to be on medications but had no other choice to treat my anxiety symptoms.
She continued:
Xanax saved my life from never-ending anxiety. It made me calmer and also helped in treating my insomnia. I want to emphasize that this medication works incredibly well when used correctly as prescribed by your doctor.
What is the clinical significance of Xanax?
Xanax, a brand for Alprazolam, is a benzodiazepine which mimics the effects of the inhibitory neurotransmitter, gamma-aminobutyric acid (GABA), and results in reduced anxiety, relaxed muscles and better sleep (1). It is used to treat and manage several health conditions such as:
- Depression
- Seizures
- Insomnia
Does Xanax work for everyone?
Xanax does not work the same for everyone. Our bodies and minds are unique, and that means our responses to medications can vary widely.
Xanax can help ease the symptoms of anxiety and depression for some individuals. However, several factors can influence its effectiveness.
Firstly, an individual’s physiology plays a vital role. Xanax’s mechanism of action involves brain chemistry, and not everyone’s brain chemistry responds in the same way.
Moreover, the effectiveness of Xanax can be influenced by the presence of other medications. Drug interactions can be complex and certain combinations might reduce the drug’s efficacy.
What are the early side effects of Xanax?
Early side effects of Xanax include (2,3):
- Drowsiness
- Dizziness
- Lightheadedness
- Difficulty concentrating
- Slurred speech
- Memory problems
- Headache
- Blurred vision
- Nausea or vomiting
Xanax, a short-acting benzodiazepine, can be taken with or without food. Its effects start to wear off in 8-10 hours. Returning to your usual state of anxiety does not justify increasing your medication on your own without consulting your doctor.
Addiction potential
Abusing Xanax can result in addiction (4). It is only beneficial when used in appropriate amounts by consulting your healthcare provider. Taking Xanax in excess amounts can destroy your mental and physical well-being.
So it is advisable to take Xanax only after a recommendation from your healthcare provider.
Conclusion
In my opinion, Xanax has a high success rate in treating conditions like anxiety and panic disorders, offering relief for many individuals. However, it is important to note that success rates can vary based on individual responses and the proper management of the medication.
According to the available information, the success of Xanax is contingent upon careful monitoring, proper use, and in-depth consideration of individual circumstances.
Was this helpful?
References
2.-
AHFS® Patient Medication Information. Alprazolamhttps://medlineplus.gov/druginfo/meds/a684001.html
